Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
ms decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
ms decrease » _ decrease (Expand Search), mean decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1681
-
1682
-
1683
-
1684
-
1685
-
1686
-
1687
-
1688
Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts
Published 2009“…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
-
1689
Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts
Published 2009“…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
-
1690
Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts
Published 2009“…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
-
1691
Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts
Published 2009“…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
-
1692
Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts
Published 2009“…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
-
1693
Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts
Published 2009“…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
-
1694
-
1695
Effect of incubation time on IC<sub>50</sub>s for zanamivir, oseltamivir and peramivir.
Published 2011“…(A) Final higher IC<sub>50</sub> values for binding of zanamivir without preincubation compared to preincubation and the decreases in IC<sub>50</sub>s without preincubation over the 60 min correlate with slow binding. …”
-
1696
Table_4_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX
Published 2020“…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …”
-
1697
Table_1_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX
Published 2020“…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …”
-
1698
Table_2_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX
Published 2020“…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …”
-
1699
-
1700